Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Jupiter Neurosciences, Inc. (JUNS) had Debt to Equity Ratio of 0.04 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-2.44M |
|
-- |
|
-- |
|
$3.09M |
|
$-3.09M |
|
$0.65M |
|
$-2.44M |
|
$-2.44M |
|
$-2.44M |
|
$-2.44M |
|
$-2.44M |
|
$-2.44M |
|
$-3.09M |
|
$-3.05M |
|
28.78M |
|
28.78M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$4.65M |
|
-- |
|
$1.55M |
|
$6.20M |
|
$2.01M |
|
-- |
|
$0.02M |
|
$2.03M |
|
$4.17M |
|
$4.17M |
|
$4.17M |
|
33.10M |
|
| Cash Flow Statement Financials | |
$-3.91M |
|
-- |
|
$7.65M |
|
$0.03M |
|
$3.77M |
|
$3.74M |
|
$1.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.31 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.04 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-58.48% |
|
-58.48% |
|
-39.33% |
|
-58.48% |
|
$0.13 |
|
$-0.14 |
|
$-0.14 |
|